Complications of single‐port robot‐assisted radical prostatectomy: multi‐institutional analysis from the Single‐Port Advanced Research Consortium (SPARC)

Objective To evaluate the perioperative complications of single‐port robot‐assisted radical prostatectomy (SP‐RARP). Patients and Methods A retrospective review was performed on the prospectively maintained, Institutional Review Board‐approved, multi‐institutional Single‐Port Advanced Research Consortium (SPARC) database. A total of 1103 patients were identified who underwent three different approaches of SP‐RARP between 2019 and 2022 using the purpose‐built SP robotic platform. In addition to baseline clinical, perioperative outcomes, this study comprehensively analysed for any evidence of intraoperative complication, as well as postoperative complication and readmission within 90 days of the respective surgery. Results Of the 244, 712, and 147 patients who underwent transperitoneal, extraperitoneal, and transvesical SP‐RARP, respectively, intraoperative complications were noted in five patients (0.4%), all of which occurred during the transperitoneal approach. Two patients had bowel serosal tears, two had posterior button‐holing of the bladder necessitating repair, and one patient had an obturator nerve injury. Postoperative complications were noted in 143 patients (13%) with major complications (Clavien–Dindo Grade ≥III) only identified in 3.7% of the total cohort. The most common complications were lymphocele (3.9%), acute urinary retention (2%), and urinary tract infection (1.9%). The 90‐day re‐admission rate was 3.9%. Conclusion The SP‐RARP is a safe and effective procedure with low complication and readmission rates regardless of the approach. These results are comparable to current multi‐port RARP literature.